Moreover, the APOE4 status appears to have an influence on the gut microbiome in patients with AD as well as Apolipoprotein E (APOE) transgenic mice, particularly regarding butyrate-producing microbes (31). This evidence concerns the gene APOE and Alzheimer disease.